About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Use of PCR-Sars-CoV-2 in Children

NCT04412317·2 sites·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Corinne Levy, MD
CONTACT
148850404 corinne.levy@activ-france.fr

Lead

Centre Hospitalier Intercommunal Creteil

With

Association Clinique Thérapeutique Infantile du val de Marne
Groupe de Pathologies Infectieuses Pédiatriques (GPIP)
AFPA
Francophone Pediatric Resuscitation and Emergency Group (GFRUP)

Age

0–14

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Children under 15 years of age
Prescription of a PCR-Sars-CoV-2
VIGIL information note given to parents

You may not be if

Refusal to participate by the patient, family member or legal representative (depending on the situation)

The record

StatusUnknown

PhaseNo phase

Taking part12,000

StartedJun 2020

UpdatedFeb 8, 2023

Conditions

Where2

ACTIV network
Créteil, France
PARI network
Créteil, France

Clareo Health | Use of PCR-Sars-CoV-2 in Children